The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanoma. Poizeau F, Balusson F, Lemaitre F, Tron C, et al. Br J Dermatol 2023 Feb 10:ljac085. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Poizeau F, Balusson F, Lemaitre F, Tron C, et al. The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanoma. Br J Dermatol 2023 Feb 10:ljac085. doi: 10.1093.
PMID: 36760148